MDMA-like behavioral effects of N-substituted piperazines in the mouse
-
Add time:08/31/2019 Source:sciencedirect.com
Few studies have characterized the subjective effects of N-substituted piperazines, but these drugs show potential for abuse in humans, and have often been associated with MDMA (“ecstasy”) in this regard. The aim of the present study was to test the capacity of N-substituted piperazines to induce a head twitch response, alter locomotor activity, and induce MDMA-like discriminative stimulus effects in mice. Various doses of l-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl) piperazine (TFMPP), 1-(3-methoxybenzyl) piperazine (m-MeO-BZP) or meta-chlorophenyl piperazine (m-CPP) were administered to mice to determine the effects on these behavioral endpoints. BZP, but not its meta-methoxyl analogue, increased locomotor activity in a dose-dependent manner; the phenylpiperazines and m-MeO-BZP only decreased locomotor activity. TFMPP was the only compound active in the head twitch assay, eliciting a moderate head twitch response which was comparable to that previously observed with the MDMA enantiomers. BZP, TFMPP and m-CPP fully substituted in S(+)-MDMA-trained animals, but did not elicit significant drug lever responding in mice trained to discriminate R(−)-MDMA. m-MeO-BZP partially substituted for both training drugs. The present results suggest that BZP has stimulant-like effects, and that TFMPP has hallucinogen-like effects. Their structural analogues, however, do not share these behavioral profiles. Further studies into the relationships between the N-substituted piperazines and MDMA are warranted.
We also recommend Trading Suppliers and Manufacturers of N-(3-Trifluoromethylphenyl)piperazine (cas 15532-75-9). Pls Click Website Link as below: cas 15532-75-9 suppliers
Prev:Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine
Next:Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Rapid communicationStimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine☆09/02/2019
- Original articleSynthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects09/01/2019
- Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl) piperazine08/30/2019
- Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment08/29/2019
- Hepatotoxicity of piperazine designer drugs: Comparison of different in vitro models08/28/2019
- Mise au pointLa 1-benzylpipérazine (BZP) et la 1-(3-trifluorométhylphényl)pipérazine (TFMPP) : émergence de deux substances donnant lieu à un usage abusif1-benzylpiperazine (BZP) and 1-(3-trifluorométhylphényl)pipérazine (TFMPP): Emergence of two agents which lead to misuse08/27/2019
- Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine08/26/2019
- ReviewPiperazine compounds as drugs of abuse08/25/2019
- ORIGINAL ARTICLEDevelopment of a targeted GC/MS screening method and validation of an HPLC/DAD quantification method for piperazines–amphetamines mixtures in seized material08/24/2019


